Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What are the key principles of Good Clinical Practice (GCP) and why is adherence required for regulatory submissions?

Good Clinical Practice is built on conducting research ethically, obtaining informed consent, ensuring data reliability, and protecting study subjects. These elements ensure participants’ rights and welfare are safeguarded and that the results are credible and verifiable. When sponsors submit trial data to regulators, authorities rely on GCP-compliant studies to assess safety and efficacy; adherence provides confidence that the data are accurate, complete, and traceable from source documents to the final report, with proper monitoring and documentation. The chosen description captures these essential principles and why they matter for regulatory submissions. Other options either misplace emphasis on marketing, post-market activities, or trial design features, or imply withholding data or consent, which would not meet GCP standards and would undermine regulatory acceptability.

Good Clinical Practice is built on conducting research ethically, obtaining informed consent, ensuring data reliability, and protecting study subjects. These elements ensure participants’ rights and welfare are safeguarded and that the results are credible and verifiable. When sponsors submit trial data to regulators, authorities rely on GCP-compliant studies to assess safety and efficacy; adherence provides confidence that the data are accurate, complete, and traceable from source documents to the final report, with proper monitoring and documentation. The chosen description captures these essential principles and why they matter for regulatory submissions. Other options either misplace emphasis on marketing, post-market activities, or trial design features, or imply withholding data or consent, which would not meet GCP standards and would undermine regulatory acceptability.